Oxford Drug Design

Oxford, United Kingdom · Founded 2001 · Privately Held (backing)

Developer of an artificial intelligence-driven drug discovery platform designed to support the identification and development of new therapeutic candidates. Oxford Drug Design is based in Oxford, United Kingdom and was founded in 2001. Its last reported valuation was $12.7 million in Dec 2025. It has raised $16.5 million.

Last reported valuation

$12.7M

Oct 2026

Priced at

—

Total raised

$16.5M

Last round

—

How much has Oxford Drug Design raised?

$16.5Macross 0 recorded rounds

Free account

More of Oxford Drug Design with a free account

·The complete investor list: 22 names
·Watch Oxford Drug Design: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Oxford Drug Design investors

22 investors are on record for Oxford Drug Design, including Innovate UK, European Commission, SyndicateRoom and University of Oxford.

For fundraisers

Raising for a company like Oxford Drug Design?

22 investors have backed Oxford Drug Design.

See all 22 investors →

Frequently asked about Oxford Drug Design

How much has Oxford Drug Design raised?: Oxford Drug Design has raised $16.5M in total across 0 recorded funding rounds.